Abstract
The Oxazolidinones are a promising novel chemical synthetic class of antibiotics identified in the last two decades and have been subjected to intensive discovery efforts. They possess impressive antibacterial activity against Grampositive pathogens. Oxazolidinones act through a unique mechanism of inhibitory bacterial protein biosynthesis. Linezolid (ZyvoxTM) has been the only drug of oxazolidinone class to reach the market after USFDA approval. Here we review our efforts directed to the discovery of novel oxazolidinone antibacterials evolved through structure-activity relationship (SAR) and an overview of contemporary on going efforts.
Keywords: Oxazolidinones, Antibacterials, antibiotics, structure-activity relationship (SAR), antibacterial activity, synthetic compound
Anti-Infective Agents in Medicinal Chemistry
Title: Oxazolidinone Antibacterials and Our Experience
Volume: 7 Issue: 4
Author(s): Brijesh Kumar Srivastava, Rina Soni, Jayendra Z. Patel, Mukul R. Jain and Pankaj R. Patel
Affiliation:
Keywords: Oxazolidinones, Antibacterials, antibiotics, structure-activity relationship (SAR), antibacterial activity, synthetic compound
Abstract: The Oxazolidinones are a promising novel chemical synthetic class of antibiotics identified in the last two decades and have been subjected to intensive discovery efforts. They possess impressive antibacterial activity against Grampositive pathogens. Oxazolidinones act through a unique mechanism of inhibitory bacterial protein biosynthesis. Linezolid (ZyvoxTM) has been the only drug of oxazolidinone class to reach the market after USFDA approval. Here we review our efforts directed to the discovery of novel oxazolidinone antibacterials evolved through structure-activity relationship (SAR) and an overview of contemporary on going efforts.
Export Options
About this article
Cite this article as:
Srivastava Kumar Brijesh, Soni Rina, Patel Z. Jayendra, Jain R. Mukul and Patel R. Pankaj, Oxazolidinone Antibacterials and Our Experience, Anti-Infective Agents in Medicinal Chemistry 2008; 7 (4) . https://dx.doi.org/10.2174/187152108785908820
DOI https://dx.doi.org/10.2174/187152108785908820 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology Vitamin D and Acute Respiratory Tract Infection
Current Respiratory Medicine Reviews Synthesis and Biological Activity of Fused Heteropolycyclic Systems Containing an Indole Moiety
Current Organic Synthesis Pulmonary Complications in Diabetes Mellitus: The Role of Glycemic Control
Current Drug Targets - Inflammation & Allergy A HR-MS Based Method for the Determination of Chorismate Synthase Activity
Protein & Peptide Letters Novel Research Strategies of Benzimidazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Ketamine as Antidepressant? Current State and Future Perspectives
Current Neuropharmacology Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects
Current Vascular Pharmacology Key Amino Acids of Arabidopsis VKOR in the Activity of Phylloquinone Reduction and Disulfide Bond Formation
Protein & Peptide Letters Synthesis and In vitro Antibacterial, Antitubercular Studies of Novel Fluoroquinolones Analogs Containing 4-substituted Sec Amine
Current Bioactive Compounds Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
Current Drug Targets Recent Developments in the Chemistry and Biology of G-Quadruplexes with Reference to the DNA Groove Binders
Current Pharmaceutical Design 2D QSAR Analysis of Substituted Quinoxalines for their Antitubercular and Antileptospiral Activities
Current Computer-Aided Drug Design Structure-Based Virtual Screening for the Identification of High Affinity Compounds as Potent VEGFR2 Inhibitors for the Treatment of Renal Cell Carcinoma
Current Topics in Medicinal Chemistry The Changing Face of Tobacco Use Among United States Youth
Current Drug Abuse Reviews ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines
Current Topics in Medicinal Chemistry From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry Nanodelivery Systems for Mucosal Vaccines
Recent Patents on Nanomedicine Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy